Pharmafile Logo

Innovative Trials named Best global Patient Recruitment Company of 2021

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

- PMLiVE

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021. The awards, organised by Global Health & Pharma and now in their sixth year, aim to recognise ‘innovation, determination and outstanding levels of care demonstrated by those who place our wellbeing at the forefront of their practice’.

Founded in 2010, Innovative Trials is a UK-based company that works with some of the biggest pharmaceutical companies and Clinical Research Organisations (CROs) globally to help them reach their patient recruitment targets for trials, keep patients engaged and avoid costly delays in bringing effective new treatments to market. With a mission to accelerate recruitment to help bring treatments to patients sooner, the company has so far:

● worked on nearly 200 clinical trials
● recruited around 40,000 people into clinical trials
● played a part in six new treatments being approved for patients across the world.

In 2020, Innovative Trials also launched a campaign alongside two other organisations to ensure patients from under-represented ethnic groups are fairly represented in UK clinical and health research.

Kate Shaw, founder and CEO of Innovative Trials, said: “We are thrilled to receive such a ringing endorsement of our work, which is entirely due to the dedication of every single member of the team. At the heart of what we do is the drive to get life-changing medicines to patients more quickly; any delays to the clinical trial process inevitably means delays in getting potentially effective treatments to those who need them most. Indeed, one of our areas of expertise lies in supporting trials in danger of failing due to lack of participants. We work closely with sites and local communities to develop tailored strategies to engage, recruit and retain patients to ensure the trial can continue. It is one of the reasons our clients come back to us again and again.”

The Healthcare & Pharmaceutical Award is the second accolade to be given to Innovative Trials this year. The company was presented with a Queen’s Award for Enterprise in International Trade in June for its work to help bring new medicines to market.

For more information about Innovative Trials, visit www.innovativetrials.com

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023

Patient recruitment company, Innovative Trials, nominated a finalist in prestigious award

UK-based patient recruitment company celebrates an incredible achievement in a national award nomination

[Free Case Study Booklet] Accelerating Patient Recruitment in a global rare disease trial

See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study

Pride Month 2023 – Innovative Trials

Innnovative Trials' Equality & Diversity committee celebrates Pride Month

[Free Whitepaper] 5 Principles for Greater Diversity in Patient Recruitment

Discover how community engagement could enhance diversity in clinical trials patient recruitment

Innovative Trials attended the Inspire Hertfordshire Award gala dinner

Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.

Navigating patients step by step on their clinical trial journey

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

Innovative Trials responds to national recommendations to tackle UK clinical trial decline

Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

Innovative Trials nominates Eloise Moffett as New VP of Commercial

Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...